Protara Therapeutics, Inc. financial data

Symbol
TARA on Nasdaq
Location
345 Park Avenue South, 3 Rd Floor, New York, NY
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2025 - Nov 10, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 1.49K % +26.8%
Debt-to-equity 8.18 % -41.8%
Return On Equity -35.1 % +37.2%
Return On Assets -32.5 % +33.8%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 38.6M shares +87%
Common Stock, Shares, Outstanding 38.6M shares +87%
Entity Public Float 35M USD +94.4%
Common Stock, Value, Issued 39K USD +85.7%
Weighted Average Number of Shares Outstanding, Basic 42.3M shares +89.3%
Weighted Average Number of Shares Outstanding, Diluted 42.3M shares +89.3%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 39M USD +36.5%
General and Administrative Expense 20.8M USD +20.1%
Operating Income (Loss) -59.8M USD -30.3%
Nonoperating Income (Expense) 6.88M USD +79.4%
Net Income (Loss) Attributable to Parent -52.9M USD -25.8%
Earnings Per Share, Basic -1 USD/shares +57.4%
Earnings Per Share, Diluted -1 USD/shares +57.4%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 12.6M USD -75.8%
Marketable Securities, Current 120M USD +304%
Other Assets, Current 218K USD +7167%
Assets, Current 136M USD +59.4%
Property, Plant and Equipment, Net 828K USD -25.3%
Operating Lease, Right-of-Use Asset 3.45M USD -23.5%
Other Assets, Noncurrent 21K USD -36.4%
Assets 145M USD +53.7%
Accounts Payable, Current 4.5M USD +96.3%
Employee-related Liabilities, Current 2.24M USD
Accrued Liabilities, Current 4.19M USD -20.6%
Liabilities, Current 9.91M USD +14.7%
Operating Lease, Liability, Noncurrent 2.44M USD -33.4%
Liabilities 12.3M USD +0.37%
Accumulated Other Comprehensive Income (Loss), Net of Tax 143K USD +393%
Retained Earnings (Accumulated Deficit) -285M USD -22.8%
Stockholders' Equity Attributable to Parent 132M USD +61.7%
Liabilities and Equity 145M USD +53.7%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -14.7M USD -41.8%
Net Cash Provided by (Used in) Financing Activities 1.73M USD
Net Cash Provided by (Used in) Investing Activities -58.4M USD -353%
Common Stock, Shares Authorized 100M shares 0%
Common Stock, Shares, Issued 38.6M shares +87%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 13.3M USD -74.7%
Deferred Tax Assets, Valuation Allowance 72.5M USD +37.6%
Deferred Tax Assets, Gross 74.3M USD +36.8%
Operating Lease, Liability 3.66M USD -22.8%
Depreciation 83K USD 0%
Payments to Acquire Property, Plant, and Equipment 44K USD
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -52.8M USD -26.1%
Lessee, Operating Lease, Liability, to be Paid 4.02M USD -25.4%
Property, Plant and Equipment, Gross 2.13M USD +0.61%
Operating Lease, Liability, Current 1.22M USD +13.1%
Lessee, Operating Lease, Liability, to be Paid, Year Two 1.43M USD 0%
Lessee, Operating Lease, Liability, to be Paid, Year One 1.43M USD +2.44%
Operating Lease, Weighted Average Discount Rate, Percent 0.07 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 364K USD -44.3%
Lessee, Operating Lease, Liability, to be Paid, Year Three 718K USD -49.8%
Deferred Tax Assets, Operating Loss Carryforwards 37.2M USD +21%
Preferred Stock, Shares Authorized 10M shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 87K USD -87.9%
Operating Lease, Payments 332K USD 0%
Additional Paid in Capital 417M USD +32.9%
Deferred Tax Assets, Net of Valuation Allowance 1.76K USD
Share-based Payment Arrangement, Expense 4.67M USD -23%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%